---
title: 'Investigating the use of finerenone in children with chronic kidney disease
  and proteinuria: design of the FIONA and open-label extension studies'
date: '2024-03-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38509517/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240321180555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: FIONA is evaluating the use of finerenone in children with
  CKD and proteinuria. Should safety, tolerability, and efficacy be demonstrated,
  finerenone could become a useful additional therapeutic agent in managing proteinuria
  and improving kidney outcomes in children with ...'
disable_comments: true
---
CONCLUSION: FIONA is evaluating the use of finerenone in children with CKD and proteinuria. Should safety, tolerability, and efficacy be demonstrated, finerenone could become a useful additional therapeutic agent in managing proteinuria and improving kidney outcomes in children with ...